Physician profile
Jack E Runnels
NPI 1710627617
$405.91
in general payments reported to CMS, 2019-2025
12 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $66.42 · 2023: $31.99 · 2024: $117 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $148.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbvie INC. | $56.56 | 2023-2025 | Skyrizi |
| Amgen INC. | $30.55 | 2024 | Krystexxa |
| Otsuka America Pharmaceutical, INC. | $28.82 | 2024 | Rexulti |
| Hologic Sales and Service, LLC | $23.74 | 2024 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $20.99 | 2022 | |
| Lucid Diagnostics INC. | $20.26 | 2024 | |
| Astellas Pharma US INC | $17.40 | 2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $17.38 | 2022 | |
| Lilly USA, LLC | $14.04 | 2022 | |
| Janssen Pharmaceuticals, INC | $14.01 | 2022 | |
| Phathom Pharmaceuticals, INC. | $13.24 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Runnels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.